EGFR and breast cancer: For example, CQ has been shown to overcome primary resistance of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in A549 lung cancer cells [16] and trastuzumab in HER-2 positive breast cancer [17].